Company Filing History:
Years Active: 2017
Title: Ludwig Englmeier: Innovator in Pharmaceutical Composition
Introduction
Ludwig Englmeier is a notable inventor based in Holzkirchen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on macitentan.
Latest Patents
Englmeier holds a patent for a pharmaceutical composition containing crystalline macitentan. This invention relates to an oral solid dosage form, specifically a tablet, that comprises macitentan free base polymorphic form I. His work in this area has the potential to impact the treatment of various medical conditions.
Career Highlights
Englmeier is currently employed at Sandoz AG, a global leader in generic pharmaceuticals and biosimilars. His role at the company allows him to further his research and development efforts in the pharmaceutical industry.
Collaborations
Englmeier has collaborated with notable colleagues, including Marijan Stefinovic and Johannes Raneburger. These partnerships have contributed to the advancement of his research and the successful development of his patent.
Conclusion
Ludwig Englmeier's contributions to pharmaceutical innovation, particularly through his patent on macitentan, highlight his role as a key figure in the industry. His work continues to influence the field and improve patient outcomes.